Dave Wohlpart serves as President of DLW BIOTECH CONSULTING LLC since January 2023. With over three decades of experience at Merck, Wohlpart has held various roles including Director and Executive Director, currently functioning as Director and HPV Product Technical Leader for Merck's major vaccine franchise. Responsibilities include coordinating strategic technical aspects across multiple divisions such as Quality and Supply Chain, as well as overseeing a team of 60-90 personnel for Technical Operations related to microbial bulk vaccine production valued at $1.5 billion. Wohlpart's career at Merck began in engineering positions focused on capital projects, including the design and validation of a $200 million biotechnology facility. Educational credentials include a Ph.D. in Chemical Engineering from the University of Virginia and a B.S. in Chemical Engineering from Virginia Tech.
This person is not in any teams
This person is not in any offices